Avalyn Pharma Inc. Common Stock
NASDAQ:AVLNMedical - Pharmaceuticals
+$0.52 today
- Market cap
- $1.23B
- Beta
- 0.00
Volume 0.40M
Average 0.51M
AVLN Total Current Assets
All assets expected to be converted to cash or used up within one year.
Total Current Assets history
Currency unavailable · from the balance sheet
No Total Current Assets data reported for this period type.
Total Current Assets vs competitors
How AVLN compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $1.63B USD | -21.5% | +12.1% | 77.7% | |
| Mar 2026 | $251.16M USD | -8.2% | +7.5% | 33.7% | |
VCREVicore Pharma Holding AB | Jun 2026 | SEK 95.52M SEK | — | — | 99.6% |
| Mar 2026 | $91.73M USD | +34.0% | +27.3% | 56.6% | |
AVLNAvalyn Pharma Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding AVLN) | — | -8.2% | +12.1% | 67.2% | |
Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Avalyn Pharma Inc. Common Stock
NASDAQ:AVLN
Intrinsic Alpha fair value
Locked
Current Price
$27.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.